As people get older, their immune system grows weaker, and so effectiveness wanes in people older than
65. Most people who die of the seasonal flu are older than
65; some studies suggest that a
vaccine lowers the number of flu-related deaths in this group by as little as 5 percent.
Rather than make a risky investment to research a vastly more effective flu vaccine, producers have continued to fine-tune the existing one.